Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could group doctor visits help teens with diabetes?

NCT ID NCT06923046

Symptom relief Sponsor: Children's Hospital Los Angeles Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether shared medical appointments—where teens with type 2 diabetes meet their doctor in a group setting with educational activities—are a good way to deliver care. 160 teens aged 12-18 will either receive standard care or attend quarterly group clinics. Researchers will measure clinic attendance, blood sugar control, and patient satisfaction to see if this model improves outcomes and well-being.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
shared medical appointments (group clinic visits with education and support)
What this could lead to
If it works, this could offer a more engaging and supportive way to manage type 2 diabetes in teens, potentially improving their health and quality of life.
What could go wrong
This is a small, early-stage trial (160 participants) testing a care model, not a new drug. The results may not apply to all teens or clinics, and the main goal is to see if the approach is acceptable, not to prove it works better.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 160 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2025

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

12 to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Patient/AYA Participants Inclusion Criteria: * Receives care for type 2 diabetes at either CHLA or UCSF * English speaking youth * Youth prescribed medication for type 2 diabetes * English or Spanish speaking caregivers * Age 12 to 18 years old at the time of enrollment * Willingness to attend clinic visits and participate in group session (if randomized to Team Clinic), complete surveys Exclusion Criteria: * Participants who are non-verbal or unable to participate in group activities and discussions * Pregnancy * Inability or unwillingness of individual or legal guardian/representative to give written informed assent/consent Caregiver/Parents Participants Inclusion Criteria: * Has a child between the ages of 12 and up to 18 at the time of enrollment who receives care for T2D in the endocrinology clinic at CHLA. The child must provide consent/assent to participate as a youth participant. * Speaks English of Spanish. Over 95% of our T2D population speaks one of those two languages. Our facilitator will be bilingual in English and Spanish. It is not feasible for the facilitator to also speak another language. Having a language interpreter for discussion groups will affect the dynamics and flow of the group session * Willingness to participate in group session (if their child is randomized to Team Clinic) and complete surveys. Exclusion Criteria: -Inability or unwillingness of individual to give written informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Type 2 diabetes are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Type 2 diabetes

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Children's Hospital Los Angeles

    RECRUITING

    Los Angeles, California, 91316, United States

  • University of California, San Francisco

    NOT_YET_RECRUITING

    San Francisco, California, 94143-0434, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.